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Glycan-Foraging Systems Reveal the Adaptation of Capnocytophaga
canimorsus to the Dog Mouth
Francesco Renzi,a Pablo Manfredi,b Mélanie Dol,a Jian Fu,c Stéphane Vincent,c Guy Richard Cornelisa
Département de Biologie, Université de Namur, Namur, Belgiuma; Biozentrum der Universität Basel, Basel, Switzerlandb; Département de Chimie, Université de Namur,
Namur, Belgiumc
ABSTRACT Capnocytophaga canimorsus is known to form two kinds of cells on blood agar plates (coccoid and bacillary), evok-
ing phase variation. When grown in coculture with animal cells these bacteria appeared only as bacilli, but in the presence of
vancomycin they were round, indicating that coccoid shapes likely result from weakening of the peptidoglycan layer. Polysac-
charide utilization locus 5 (PUL5) and sialidase mutant bacteria, unable to retrieve glycans from glycoproteins, grew less than
wild-type bacteria and also appeared polymorphic unless GlcNAc was added, suggesting that C. canimorsus is unable to synthe-
size GlcNAc, an essential component of peptidoglycan. Accordingly, a genome analysis was conducted and revealed that C. cani-
morsus strain 5 lacks the GlmM and GlmU enzymes, which convert glucosamine into GlcNAc. Expression of the Escherichia coli
GlmM together with the acetyltransferase domain of GlmU allowed PUL5 mutant bacteria to grow normally, indicating that
C. canimorsus is a natural auxotroph that relies on GlcNAc harvested from the host N-glycoproteins for peptidoglycan synthesis.
Mucin, a heavily O-glycosylated protein abundant in saliva, also rescued growth and the shape of PUL5 mutant bacteria. Utiliza-
tion of mucin was found to depend on Muc, a Sus-like system encoded by PUL9. Contrary to all known PUL-encoded systems,
Muc cleaves peptide bonds of mucin rather than glycosidic linkages. Thus, C. canimorsus has adapted to build its peptidoglycan
from the glycan-rich dog’s mouth glycoproteins.
IMPORTANCE Capnocytophaga canimorsus is a bacterium that lives as a commensal in the dog mouth and causes severe infec-
tions in humans. In vitro, it forms two kinds of cells (coccoid and bacillary), evoking phase variation. Here, we show that cell
rounding likely results from weakening of the peptidoglycan layer due to a shortage of N-acetylglucosamine (GlcNAc). C. cani-
morsus cannot synthesize GlcNAc because of the lack of key enzymes. In its niche, the dog mouth, C. canimorsus retrieves Gl-
cNAc by foraging glycans from salivary mucin and N-linked glycoproteins through two different apparatuses, Muc and Gpd,
both of which are related to the Bacteroides starch utilization system. The Muc system is peculiar in the sense that the enzyme of
the complex is a protease and not a glycosylhydrolase, as it cleaves peptide bonds in order to capture glycan chains. This study
provides a molecular genetic demonstration for the complex adaptation of C. canimorsus to its ecological niche, the oral cavity
of dogs.
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Capnocytophaga canimorsus is a capnophylic gliding Gram-negative bacterium from the Bacteroidetes phylum that is part
of the normal flora of the dog mouth (1–5). Although it has not
been reported to cause infections in dogs, it causes rare but severe
infections in humans who are in contact with dogs (6, 7). The
usual syndrome is septicemia, with mortality in the range of 50%.
Patients are generally older than 40 years old, and roughly half of
them have had a splenectomy or abused alcohol. However, the
other half have had no medical history (for review, see references
8 to 10). C. canimorsus 5, a strain isolated from a patient with
septic shock (11), has a lipopolysaccharide that triggers little in-
flammation (2, 11–13) and confers significant resistance to
phagocytosis (2), antimicrobial peptides (12), and complement
killing (2). Its genome, which consists of a single 2.5-Mb replicon
(14), contains 13 so-called polysaccharide utilization loci (PUL)
(15), a hallmark of Bacteroidetes bacteria (16). PUL typically en-
code polysaccharide-harvesting complexes made of several lipo-
proteins anchored in the outer membrane and that face the out-
side of the cell, as well as a TonB-dependent transporter. Some
lipoproteins are devoted to glycan binding, while others are spe-
cific hydrolases. The archetype of such complexes is the Bacte-
roides thetaiotaomicron starch utilization system (Sus), initially
described by Salyers and colleagues (17–20). C. canimorsus grows
readily on blood agar plates and in coculture with animal cells but,
surprisingly, it does not grow as well in the absence of animal cells
or when it is separated from animal cells by a membrane, indicating
that it relies on cells for nutrition (21). Unexpectedly, C. canimorsus
does not damage the cells but instead deglycosylates the cellular
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surface-exposed N-glycoproteins via its Gpd complex, encoded by
PUL5 (15, 21, 22). The Gpd complex consists of a SusC-like porin
(GpdC), a SusD-like binding protein (GpdD), two ancillary lipopro-
teins (GpdEF), and an endo--N-acetylglucosaminidase (GpdG)
which cleaves the N-linked oligosaccharide after the first
N-acetylglucosamine (GlcNAc) residue (22). The Gpd complex
deglycosylates not only surface glycoproteins but also soluble glyco-
proteins, likehumanIgG(22)and transferrin (23).Deglycosylation is
required forgrowth incoculturewithanimal cellsbutalso for survival
in themouse (15, 21). In the initial descriptionof the species, Brenner
et al. (1) reported that C. canimorsus cultivated on blood agar plates
appeared as bacilli but also in different forms, including longer rods,
filaments that are often curved, spindle shaped, and coccoid (1),
which suggests that C. canimorsus undergoes some form of phase
variation.
In the present manuscript, we show that C. canimorsus 5 is a
natural auxotroph for GlcNAc that is missing the glmM and glmU
genes, which enable bacteria to convert glucosamine intoGlcNAc.
The lack of GlcNAc leads to impaired peptidoglycan (PG) assem-
bly and bacterial death, explaining the polymorphism seen on
blood agar plates in the original description of the species (1).
C. canimorsus harvests GlcNAc not only from host N-linked gly-
coproteins through the PUL5-encoded Gpd complex but also
from mucin through the PUL9-encoded Muc complex. We pro-
pose that the GlcNAc auxotrophy, which contributes to virulence
(21), results from the adaptation ofC. canimorsus as a commensal
of the glycan-rich dog mouth.
RESULTS
C. canimorsus polymorphism is due to N-acetylglucosamine
starvation. As reported early on (1), wild-type (wt) C. canimorsus
5 bacteria grown for 2 days on blood agar plates have different
morphologies, ranging from filaments to coccoid forms (Fig. 1A).
The coccoid forms strongly resemble the cells formed by Esche-
richia colimutant strains that are unable to synthesize aminosug-
ars (24). When glucosamine or GlcNAc is not provided in the
medium, these mutants cannot synthesize glucosamine-6-P, and
they form spheroplasts due to a reduction in PG synthesis (24).
We thus speculated that the polymorphism observedwithC. cani-
morsus 5 could be due to a similar reason. In order to see whether
this alteration of cell morphology was due to aminosugar starva-
tion and not some kind of phase variation, we supplemented the
blood agar plates with 0.005% GlcNAc. As shown in Fig. 1A, the
addition of GlcNAc significantly reduced the formation of abnor-
mal forms, indicating that aminosugar starvation, rather than
phase variation, could be responsible for the observed polymor-
phism of wt C. canimorsus bacteria grown on blood agar plates.
PUL5 mutants grown on HEK293 cells are polymorphic due
to a defect in peptidoglycan synthesis. In coculturewithHEK293
cells,C. canimorsus 5 bacteria deprived of the PUL5-encoded Gpd
complex reach a biomass that is 10-fold lower than that of wt
C. canimorsus 5 bacteria (15, 22) (Fig. 1B). Since this growth defect
can be rescued by supplementation of the medium with GlcNAc
(15) (Fig. 1B), we hypothesized it could mimic the growth defect
of wt bacteria on blood agar plates, and we examined the mor-
phology of wt and PUL5 mutant bacteria after 24 h of coculture
with HEK293 cells. Interestingly, while wt bacteria showed a bac-
illary form, PUL5mutants appeared elongated, enlarged, or com-
pletely round (Fig. 1C). As shown in Fig. S1A and B in the supple-
mental material, PUL5 mutants progressively changed their
morphology while they stopped dividing, suggesting that growth
arrest and aberrant morphology are two linked phenomena. In
contrast, in the presence of GlcNAc, PUL5 mutant bacteria had
the same morphology as wt bacteria (Fig. 1C), suggesting that
GlcNAc starvation affects PGbiosynthesis. In order to seewhether
a defect in PG biosynthesis determines the same growth arrest and
cell rounding, we added vancomycin (25) in the coculture of
HEK293 cells andwtC. canimorsus 5. As shown in Fig. 1D (see also
Movie S1 in the supplementalmaterial), the addition of vancomy-
cin transformed wt C. canimorsus 5 bacteria into round cells, sim-
ilar to those observed with PUL5mutant bacteria (seeMovie S2 in
the supplemental material). These results suggest that PUL5 mu-
tant bacteria, which cannot harvest host N-linked glycans, stop
growing and change their cell shape because starvation of amino-
sugars leads to defects in peptidoglycan synthesis.
Sialidase mutants also have a peptidoglycan synthesis defect.
The PUL5-encoded Gpd complex works in concert with a
periplasmic sialidase (SiaC) whose activity is crucial for the sub-
sequent processing of the cleaved glycan chains (22). Since a siaC
deletion mutant also shows reduced growth on HEK293 cells
which can be rescued by addition of aminosugars (21), we asked
whether the bacterial cell shape of a siaC mutant would also be
affected. Indeed, a siaCmutant cocultivatedwithHEK293 cells for
24 h also showed aberrantmorphologies: elongated, enlarged, and
completely round (Fig. 1E). Addition of GlcNAc restored the nor-
mal cell shape (Fig. 1E). We concluded from this result that the
inability to metabolize host N-linked glycans, due to either block-
ade of glycan chain cleavage and import (PUL5 deletion) or block-
ade of the first step of glycan processing in the periplasm (siaC
deletion), results in aminosugar starvation. This starvation is
likely to affect PG synthesis, leading to the appearance of aberrant
cell shapes and growth arrest.
C. canimorsus 5 is missing the genes glmM and glmU. Since
C. canimorsus 5 appears to be unable to synthesize GlcNAc, we
performed a Delta BLAST search of its genome (26) for homologs
ofE. coli enzymes involved in PGbiosynthetic pathways. As shown
in Fig. 2A, we could identify genes encoding all the PG biosyn-
thetic enzymes except for three: GlmS, GlmU, and GlmM, which
convert fructose-6-P into UDP-N-acetylglucosamine (UDP-
GlcNAc). GlmS is a glucosamine-6-P-synthase responsible for the
conversion of fructose-6-P into glucosamine-6-P; GlmM is a
phosphoglucosamine mutase that converts glucosamine-6-P into
glucosamine-1-P; GlmU is a bifunctional enzyme, with a
C-terminal glucosamine-1-P–N-acetyltransferase domain that
converts glucosamine-1-P into N-acetylglucosamine-1-P and an
N-terminal N-acetylglucosamine-1-P uridyltransferase domain
that converts GlcNAc-1-P into UDP-GlcNAc (27). Since the lack
of any of these enzymatic activities is lethal in E. coli (27), we
assumed that it is the lack of these enzymes that makes C. cani-
morsus dependent on exogenous GlcNAc for growth. If this hy-
pothesis were correct, expression of these three enzymes in PUL5
mutant bacteria would enable them to synthesize GlcNAc and
restore growth and bacterial shape in coculture with HEK293
cells. We cloned the three E. coli glm genes alone and in combina-
tion in a C. canimorsus expression vector (23) and monitored the
growth and morphology of recombinant PUL5mutants in cocul-
ture with HEK293 cells. PUL5-deficient bacteria expressing both
GlmU and GlmM grew to the same extent as wt and showed a
normal shape, indicating that these enzymatic activities allow
C. canimorsus to synthesize GlcNAc (Fig. 2C and D).
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The fact that the expression of GlmM and GlmU alone was
sufficient to make PUL5mutant bacteria independent of GlcNAc
suggested that theC. canimorsus 5 genome encodes a glucosamine
synthase (GlmS) that was not identified by our BLAST search.
Furthermore, since the addition of GlcNAc to the coculture of
HEK293 cells completely restored the growth of PUL5 mutant
bacteria, we inferred thatC. canimorsus is able to synthesize UDP-
GlcNAc from GlcNAc, implying that a C. canimorsus 5 gene en-
codes aGlcNAc-1-P uridyltransferase. If this is correct, the phospho-
glucosamine mutase GlmM and only the glucosamine-1-PN-
acetyltransferasedomainofGlmUwouldbe sufficient to compensate
for thePUL5deletion.To test this hypothesis,we generated two trun-
cated GlmU protein variants: one with the first 77 residues deleted
(GlmU del78), consisting only of the glucosamine-1-PN-
acetyltransferase activity, and one with the last 125 residues deleted
(GlmU Tr331), consisting only of the N-acetylglucosamine-1-P-
uridyltransferase activity (28) (Fig. 2B). We expressed in PUL5
mutants either GlmM and GlmU del78 or GlmM and GlmU
FIG 1 N-acetylglucosamine starvation affects growth and cell shape. (A) Bright-field microscopy pictures of wt (C. canimorsus 5) bacteria grown for 48 hours
on blood agar plates in the absence or in the presence of GlcNAc (0.005%). (B) Counts of wt (C. canimorsus 5) and PUL5 (PUL5) knockout bacteria after 23
hours growth in cDMEM with or without HEK293 cells (MOI, 0.05) and in the presence or in the absence of GlcNAc (0.005%). The averages from three
independent experiments are shown. Error bars represent 1 standard deviation from the mean. See also Fig. S1A in the supplemental material. HEK293 cells
provided GlcNAc captured by the PUL5-encoded Gpd complex. Note that HEK293 cells provided more than GlcNAc to wt C. canimorsus 5. (C) Bright-field
microscopy pictures of wt (C. canimorsus 5) and PUL5 (PUL5) bacteria after 23 hours growth on HEK293 cells. See also Fig. S1B. (D) Bright-field microscopy
pictures of wt (C. canimorsus 5) bacteria grown on HEK293 cells for 12 hours and an additional 4 hours with or without vancomycin (5g/ml). See alsoMovies
S1 and S2 in the supplemental material. (E) Bright-field microscopy pictures of sialidase mutant bacteria (siaC) grown for 23 hours on HEK293 cells (MOI,
0.05) in the absence or in the presence of GlcNAc (0.005%).
Glycan Foraging and Bacterium-Host Adaptation
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Tr331, and we monitored the growth and bacterial shapes in co-
culture with HEK293 cells. As shown in Fig. 2C and D, the
expression of GlmM and the GlmU glucosamine-1-P–N-
acetyltransferase domain (GlmU del78) was sufficient to allow
PUL5mutantbacteria tobehave similarly towt.ExpressionofGlmM
and the uridyltransferase domain of GlmU (GlmU Tr331) restored
neither the growth nor the bacterial shape of PUL5mutants (Fig. 2C
and D). Quite expectedly, the expression of GlmM and GmU del78
had the same rescuing effect on siaC mutants (Fig. 2E and F). The
slight but significant differences between the growth and the cell
shape observed in PUL5 and siaC mutants expressing GlmM and
GlmU del78 and the wt could be ascribed to the reduced enzymatic
activity of GlmUdel78 compared to the full-lengthGlmU, as already
described by Pompeo and colleagues (28).
Taken together, these results indicate that the inability of
C. canimorsus 5 to synthesize GlcNAc is due to the lack of two
enzymes, a phosphoglucosaminemutase and a glucosamine-1-P–
N-acetyltransferase.
C. canimorsus 5 encodes a new N-acetylglucosamine-1-P-
uridyltransferase. In order to identify the unknown N-acetyl-
FIG 2 Heterologous expression of GlmU and GlmM in PUL5 and siaCmutant bacteria restores growth and normal cell shape. (A) Peptidoglycan biosynthetic
pathway showing C. canimorsus 5 orthologs of the E. coli enzymes. (B) Schematic representation of the E. coli GlmU bifunctional protein. The protein domains
are boxed. The recombinantmonofunctional proteins are indicated by the arrows. (C)Growth in coculturewithHEK293 cells ofPUL5 (PUL5)mutant bacteria
producing different combinations of GlmS, GlmM, GlmU, and monofunctional GlmU (MOI, 0.05; 23 h of growth). The averages from three independent
experiments are shown. Error bars represent 1 standard deviation from themean. *,P 0.05. (D)Bright-fieldmicroscopy pictures of bacteria grown for 23 hwith
HEK293 cells (MOI, 0.05). (E)Growth onHEK293 cells of of wt (C. canimorsus 5) and siaC (siaC) bacteria expressingGlmMandmonofunctional GlmU (MOI,
0.05; 23 h of growth). The averages from three independent experiments are shown. Error bars represent 1 standard deviation from the mean. **, P 0.01. (F)
Bright-field microscopy pictures of bacteria grown for 23 h on HEK293 cells (MOI, 0.05).
Renzi et al.
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glucosamine-1-P-uridyltransferase of C. canimorsus 5, we searched
the genome for gene products with an enzymatic domain similar to
that of the N-terminal N-acetylglucosamine-1-P-uridyltransferase
domainof theE. coliGlmU. It turnedout thatCcan_15070 encodes a
protein with a conserved glycosyltransferase domain (Fig. 3A). At-
tempts to knock out Ccan_15070 were unsuccessful unless C. cani-
morsus 5 could synthesize the E. coliGlmUTr331 protein, suggesting
that Ccan_15070 is an essential gene and indeed encodes an
N-acetylglucosamine-1-P-uridyltransferase.
We then generated a PUL5 Ccan_15070 double-knockout
strain complemented with the E. coli glmM and glmU genes and
monitored growth and cell morphology. As shown in Fig. 3B and
C, the strain grew to the same extent as wt and had a normal cell
shape, indicating that the deletion of Ccan_15070 could be fully
complemented by the N-acetylglucosamine-1-P-uridyltransferase
activity of the E. coli GlmU.
Finally, to test the Ccan_15070 enzymatic activity, we ex-
pressed the protein with a C-terminal Strep tag in E. coli and we
added purified Ccan_15070 to a solution of GlcNAc-1-P and
UTP. The analysis of the reaction products via high-
performance liquid chromatography (HPLC) confirmed the
production of UDP-GlcNAc (Fig. 3D). Thus, Ccan_15070 en-
codes an N-acetylglucosamine-1-P-uridyltransferase, which
we named GlmUCc.
GlcNAc is also harvested through a PUL-encoded system tar-
geting mucin. The loss of the capacity to synthesize aminosugars
during evolution implies thatC. canimorsus relies on aminosugars
from the dog mouth. In the oral cavity, one of the most abundant
glycoproteins is mucin, which is heavily glycosylated and harbors
mainly O-linked glycans. The PUL5-encoded Gpd system can
thus not harvest the mucin sugars. In order to determine if the
aminosugars frommucinO-glycans can be used to synthesize PG,
we took advantage of the fact that PUL5mutant bacteria grow less
well than wt in coculture with HEK293 cells. Hence, we tested
whether the addition of purified bovine submaxillary mucin re-
stored the growth of PUL5 bacteria. As shown in Fig. 4G and H,
FIG 3 Ccan_15070 encodes an N-acetylglucosamine-1-P uridyltransferase. (A) Schematic representation of the C. canimorsus 5 Ccan_15070 gene-encoded
N-acetylglucosamine-1-P-uridyltransferase (Uniprot ID F9Yr13). (B) Growth onHEK293 cells of wt (C. canimorsus 5), PUL5 (PUL5), and PUL5/Ccan_15070
(PUL5/Ccan_15070) double-mutant bacteria expressing GlmM and GlmU (MOI, 0.05; 23 h of growth). The averages from three independent experiments
are shown. Error bars represent 1 standard deviation from themean. (C) Bright-fieldmicroscopy picture ofPUL5Ccan_15070 doublemutant bacteria expressing
GlmM and GlmU grown for 23 h on HEK293 cells (MOI, 0.05). (D) Detection of UDP-GlcNAc production by HPLC. Incubation of recombinant Ccan_15070
with UTP and GlcNAc-1-P resulted in the production of UDP-GlcNAc. (E) No UDP-GlcNAc formation could be detected in the absence of recombinant
Ccan_15070.
Glycan Foraging and Bacterium-Host Adaptation
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FIG 4 PUL9 gene products allow mucin degradation and deglycosylation. (A) Schematic representation of the PUL9 locus. (B) Schematic drawing of the PNA
lectin target oligosaccharides. (C) PNA lectin staining of human saliva after incubation in the presence of wt C. canimorsus 5 and the 13 PUL knockout strains.
The upper band represents mucin, while the lower band represents sIgA. (D) Saliva PNA staining after incubation with wt bacteria, PUL9, and Ccan_17430
knockout bacteria. (E) Saliva PNA staining after incubation with wt bacteria, PUL9, or PUL9 bacteria expressing the only Ccan_17430 protein. (F)Western blot
analysis of human mucin 7 in saliva after incubation with wt bacteria, PUL9, or PUL9 bacteria expressing the only Ccan_17430 protein. See also Fig. S3 in the
supplemental material. (G) Growth after 23 h of wt (C. canimorsus 5), PUL5 (PUL5), PUL9 (PUL9), and PUL5/PUL9 (PUL5PUL9) mutant bacteria in the
presence of HEK293 cells with or without bovine submaxillary glandmucin (1mg/ml) or GlcNAc (0.005%) (MOI, 0.005). The averages from three independent
experiments are shown. Error bars represent 1 standard deviation from themean. (H) Bright-fieldmicroscopy picture of PUL5 (PUL5) mutant bacteria grown
for 23 h on HEK293 cells in the presence of bovine mucin (1 mg/ml) (MOI, 0.05). (I) Functional model of mucin degradation and deglycosylation. Mucin is
bound at the bacterial surface by theMucCDEG surface protein complex. TheMucGprotease cleavesmucin into glycosylated peptides that are imported into the
periplasm through the MucC pore. Terminal sialic acid is cleaved by sialidase (SiaC), and terminal sulfate groups are removed by the sulfatase. The glycan is
further processed by the sequential activity of several periplasmic exoglycosidases that allow the liberation of monosaccharides.
Renzi et al.
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addition of bovine mucin fully restored the growth and the mor-
phology of PUL5mutant bacteria.
To ascertain that salivarymucins are deglycosylated byC. cani-
morsus 5, we incubated bacteria with filtered fresh human saliva
and we analyzed the salivary glycoproteins before and after incu-
bation, by using sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis followed by staining with peanut agglutinin (PNA).
PNA recognizes terminal galactose linked to GalNAc in O-linked
oligosaccharides, a glycan structure named T-antigen (Fig. 4B)
that is abundant in mucins (29). A saliva glycoprotein with a mo-
lecular mass around 100 to 140 kDa turned out to be deglycosy-
lated after incubation with wt C. canimorsus 5 (Fig. 4C). In con-
trast, the glycosylation state of a protein with a molecular mass of
around 60 kDa was unaffected (Fig. 4C). LC-mass spectrometry
(LC/MS) analysis of the two proteins identified the higher-
molecular-mass protein as salivary mucin (MUC7 or MG2; Uni-
prot accession number Q8tax7) and the lower-molecular-mass
one as secreted IgA (sIgA, or Ig -1 chain region; Uniprot acces-
sion number P01876) (data not shown). This indicated that
C. canimorsus 5 specifically targeted MG2 glycans rather than the
sIgA ones. We reasoned that one of the 13 PULmutants could be
responsible for the T-antigen cleavage from MG2, and we tested
the 13C. canimorsus 5 PUL knockoutmutants (15). Of all the PUL
mutants, only PUL9 knockout bacteria were impaired in MG2
T-antigen deglycosylation (Fig. 4C). To ensure that mucin utili-
zation was PUL9 dependent, we generated a PUL5 PUL9 double-
knockout strain and tested whether addition of mucin restored
the growth of this mutant. As expected, addition of mucin did not
restore the growth defect of the double mutant, indicating that
mucin degradation and utilization are PUL9 dependent (Fig. 4G).
PUL9 encodes a bona fide Sus-like complex. PUL9 encodes
seven proteins (Ccan_17420 to Ccan_17490) (Fig. 4A). The
neighboring Ccan_17470 and Ccan_17450 genes encode typical
SusC-like (TonB-dependent receptor) and SusD-like proteins.
Ccan_17480 is annotated as a -galactosidase, while Ccan_17490
is a putative sulfatase. Both carry a signal peptide I and hence are
predicted to be periplasmic. Ccan_17420 is a predicted lipopro-
tein annotated as a carboxypeptidase. Ccan_17430 is predicted to
be a mucinase (30) with two BACON (Bacteroidetes-associated
carbohydrate often N-terminal domain) modules (31) and one
F5/8 typeC (32) carbohydrate bindingmodule. Ccan_17440 is the
most abundant PUL-encoded protein of the C. canimorsus 5 sur-
fome (15) and also harbors an F5/8 type C carbohydrate binding
module. Ccan_17430 (mucinase) and Ccan_17450 (SusD-like)
were also found in the surfome ofC. canimorsus 5 (15). In order to
determine whether all these proteins form with Ccan_17470
(SusC-like), a surface complex similar to the one formed by the
PUL5 products, we tagged the C terminus of the porin
Ccan_17470 and carried out a His-Strep tandem affinity purifica-
tion (see Fig. S2 in the supplemental material). The LC/MS
analysis of the eluate identified 35 proteins (see Table S1 in the
supplemental material), among which were Ccan_17450,
Ccan_17440, and Ccan_17430. Thirteen proteins were identified
in the mock eluate, of which 11 were also present in the
Ccan_17470–Strep-His eluate. No PUL9-encoded product was
identified in the mock eluate (see Table S1). These data suggest
that Ccan_17470, Ccan_17450, Ccan_17440, and Ccan_17430
form a complex at the bacterial surface. Hence, PUL9 encodes a
bona fide Sus-like complex, and we propose to call MucC the
SusC-like protein, MucD the SusD-like protein, MucG the puta-
tive mucinase, and MucE the four surface proteins (Fig. 4A). In-
terestingly, among the proteins that eluted with theMuc complex,
we also identified a sialidase. This periplasmic enzyme was previ-
ously found to be associated with the Gpd complex and involved
inN-glycan processing (22). Thus, we could also envision involve-
ment of this protein in mucin glycan processing.
The hydrolytic enzyme from the complex is not a glycan
hydrolase but a mucin peptidase. As already mentioned,
Ccan_17430 is predicted to be a mucinase (30) with two BACON
(31) and one F5/8 type C (32) carbohydrate binding modules.
Since PUL-encoded complexes are usually devoted to the hy-
drolysis of complex carbohydrates (33), the presence of a protein
hydrolase was unexpected. In order to verify the function of
Ccan_17430, we incubated human salivawithwt andCcan_17430
mutant bacteria and monitored mucin glycosylation via PNA
staining. Deletion of Ccan_17430 abolished mucin deglycosyla-
tion (Fig. 4D). Furthermore, expression of Ccan_17430 in a PUL9
deletion background led to a complete loss of mucin staining by
PNA, suggesting that Ccan_17430 alone is responsible for the ob-
served phenotype (Fig. 4E). We then monitored the presence of
mucin MG2 by Western blotting and found that it was dramati-
cally decreased, indicating that Ccan_17430 indeed encodes a pro-
tease that cleavesmucin (Fig. 4F). In agreement with this, purified
recombinant Ccan_17430 fully degradedMG2 fromhuman saliva
(see Fig. S3 in the supplemental material). Addition of EDTA
completely blocked the mucinase activity, indicating that
Ccan_17430 is a metallopeptidase. Removal of the N-terminal
conserved BACON and F5_F8 type C glycan binding domains led
to reduced mucin degradation activity, suggesting that these do-
mains could play a role in mucin binding, even though the trun-
cated protein was still able to bind and degrade MG2.
Thus, the PUL9-encoded system appears to be quite different
from the canonical ones, such as the Sus (33) and Gpd (22) sys-
tems, where a glycosylhydrolase at the bacterial surface is respon-
sible for the cleavage of complex sugars like starch or N-linked
glycans. In the case of PUL9, it is a protease that attacks mucin at
the bacterial surface, generating glycosylated peptides.
DISCUSSION
Here, we addressed the question of the phenotypic polymorphism
of C. canimorsus (1), and we found that it is linked to the adapta-
tion of C. canimorsus to its host. We showed that C. canimorsus
does not undergo a kind of phase variation but, instead, endures
aminosugar starvation, which leads to bacterial growth arrest and
cell shape change. This phenotype is a consequence of the block-
ade of peptidoglycan synthesis. These findings are explained by
the fact that C. canimorsus relies on exogenous aminosugars be-
cause it is unable to synthesize its own GlcNAc. Bacteria generally
synthesize GlcNAc starting from fructose-6-P through a series of
metabolic steps (Fig. 2A). In silico analysis of the genome of
C. canimorsus 5 did not identify orthologs of all the necessary
genes. Furthermore, coexpression of the E. coli GlmM and the
GlmU glucosamine-1-P–N-acetyltransferase domain completely
restored the growth and cell morphology of PUL5mutant bacte-
ria. We conclude from these results thatC. canimorsus is unable
to synthesize GlcNAc because of the lack of these two enzy-
matic activities. Furthermore, we identified and characterized a
novel N-acetylglucosamine-1-P-uridyltransferase that is able
to synthesize UDP-GlcNAc from GlcNAc-1-P. Differently from
E. coli and other well-studied bacteria, where the glucosamine-
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1-PN-acetyltransferase and the N-acetylglucosamine-1-P-
uridyltransferase activities are found in the same protein (GlmU)
(27), theC. canimorsus enzyme (GlmUCc) ismonofunctional, har-
boring only theN-acetylglucosamine-1-P-uridyltransferase activ-
ity and missing the glucosamine-1-PN-acetyltransferase one.
We reasoned that the loss of capacity to synthesize GlcNAc
could be a common feature in the phylum Bacteroidetes. We per-
formed an in silico search for orthologs of GlmUCc in bacteria and
found that, indeed, in Bacteroidetes, 30 out of 45 genera have a
monofunctional ortholog of GlmUCc (see Fig. S4 in the supple-
mental material). This suggests that, like C. canimorsus 5, most
Bacteroidetes are unable to synthesize GlcNAc and so rely on ex-
ogenous aminosugars.
The loss of the capacity to synthesizeN-acetylated aminosugars
during evolution implies thatC. canimorsus relies on aminosugars
from its ecological niche, the dog mouth. In agreement with this
hypothesis, we showed thatC. canimorsus 5 degrades salivary mu-
cin, a protein that is heavily O-glycosylated and very abundant in
saliva. Mucin degradation was found to depend on a mucin pro-
tease (MucG), which is, unexpectedly, part of a Sus-like surface
complex encoded by the PUL9 locus. Nevertheless, mucin degra-
dation rescued the growth of a PUL5mutant, indicating that mu-
cin aminosugars can be taken up and metabolized. Given the
structure of mucin, a protease is probably as efficient as a glycosyl
hydrolase in liberating carbohydrates. This is nevertheless the first
example of a PUL-encoded complex endowed with a protease ac-
tivity. It is also the first example of an oral commensal that utilizes
mucin via a PUL-encoded system. The C. canimorsus 5 PUL9
shows high similarity in gene composition and organization to the
Bacteroides thetaiotaomicronBT4240-50 PUL, which is induced by
the presence of mucin O-glycans (16). Like PUL9, besides the
SusC and SusD-like proteins, the BT4240-50 PUL encodes a mu-
cinase (BT4244) that has been shown to target bovine mucin in
vitro (30). However, the C. canimorsus 5 and BT mucinases share
only 27% identity. Both loci encode periplasmic -galactosidases
(Ccan_17480 and BT4241) that are 34% identical and likely to be
involved in mucin glycan processing. In B. thetaiotaomicron, the
-galactosidase has been found to be constitutively expressed
(16). PUL9 also encodes a putative periplasmic sulfatase
(Ccan_17490), which is similar (47% identity) to the mucin-
desulfating sulfatase BT3177 (34). We reason that these two en-
zymes could act on mucin glycans once the glycosylated peptides
are transferred into the periplasm through the Ccan_17470MucC
pore. Mucin O-glycans are mainly composed of core 1- and core
2-type O-glycans that can harbor terminal sulfate groups (SO3)
and sialic acid residues (29). One can thus envision a mucin deg-
radation and deglycosylationmodel wheremucin is first bound at
the bacterial surface by the MucCDGE surface complex, then
cleaved by the activity of the MucG mucinase, which liberates
glycosylated peptides that are translocated into the periplasm
through theMucC pore. Once in the periplasm, the glycopeptides
are subsequently processed by periplasmic enzymes; the removal
of terminal sialic acid residues by sialidase (Ccan_04780) and of
terminal sulfate groups by the Ccan_17490 sulfatase make galac-
tose accessible to -galactosidases (Ccan_17480, Ccan_01530,
and Ccan_15520) whose activities allow the -N-acetyl-
glucosaminidases (Ccan_16820, Ccan_20090, Ccan_03860, and
Ccan_04040) to liberate the GlcNAc residues present in core
2-type O-glycans (Fig. 4I). The PUL9 locus also encodes, down-
stream from MucG, a putative lipoprotein with a carboxypepti-
dase domain (Ccan_17420) (Fig. 4A). The presence of this enzyme
in the locus suggests an involvement in the processing of mucin
glycopeptides once in the periplasm, but this was not investigated.
Our data thus characterize a novel PUL-encoded system which
allows harvesting of mucin glycan by the activity of a mucinase at
the bacterial surface.
Overall, thiswork illustrates howa commensal that has evolved
to adapt to a specific niche becomes dependent on that niche.
C. canimorsus adapted to the dog mouth by acquiring or evolving
two Sus-like machines that are tuned to harvest sugars from saliva
and possibly from the oral epithelium. Since these machines pro-
vide abundant aminosugars,C. canimorsus could lose the capacity
to synthesize GlcNAc. Interestingly, C. canimorsus has two Sus-
like machines, allowing it to retrieve aminosugars. One of these,
the Muc machine, can only be of use in the mouth, but the other
one, the Gpdmachine, is able to sustain growth in other compart-
ments of a host and probably represents a virulence factor (15, 21).
Recently, it was shown that several members of the genus Bac-
teroides, which are able to utilize different polysaccharides, liber-
ate polysaccharide breakdown products that can be consumed by
bacteria from other species unable to grow on the polysaccharide
alone (35). These findings indicate that, in the human gut micro-
bial ecosystem, there are syntrophic interactions betweendifferent
bacteria. Similar syntrophic interactions might well occur in the
dog mouth, since the biology of C. canimorsus resembles that of
B. thetaiotaomicron, but the dog oral ecosystem is quite different
from the intestine in the sense that digestion does not start in the
dog mouth and hence the microbial competition may be more
fierce. In addition, PUL5-deficient C. canimorsus cannot be cross-
fed by wtC. canimorsus (21), which can be explained by themech-
anisms of uptake and processing of host glycans by the Gpd appa-
ratus where N-glycans are cleaved and likely immediately
imported into the periplasm (22). It is likely that the same applies
to the Muc apparatus, but this was not investigated. For C. cani-
morsus, we can thus envision a scenario that is different from the
one of the human gut. Capnocytophaga could have a more “self-
ish” behavior, as it harvests, takes up, and utilizes its own glycans,
avoiding release of polysaccharide breakdown products, which
could be utilized by competitor bacteria.
MATERIALS AND METHODS
Bacterial strains and growth conditions. (i) Conventional bacterial
growth conditions and selective agents. The strains used in this study are
listed in Table S2 in the supplemental material. Escherichia coli strains
were routinely grown in LB broth at 37°C. C. canimorsus bacteria were
routinely grown on heart infusion agar (HIA; Difco) supplemented with
5% sheep blood (Oxoid) for 2 days at 37°C in the presence of 5%CO2. To
select for plasmids, antibiotics were added at the following concentra-
tions: 10 g/ml erythromycin (Em), 10 g/ml cefoxitin (Cf), 20 g/ml
gentamicin (Gm), 100g/ml ampicillin (Ap), 50g/ml kanamycin (Km),
and 10 g/ml tetracycline (Tc). GlcNAc (catalog number A8625; Sigma)
was added at a final concentration of 0.005% when indicated.
(ii) Growth of C. canimorsus 5 bacteria with HEK293 cultured cells.
HEK293 cells were cultured in Dulbecco’s modified Eagle’s medium
(DMEM; Invitrogen)with 10% (vol/vol) fetal calf serum (Invitrogen) and
1 mM sodium pyruvate (cDMEM). Cells were grown in medium without
antibiotics in a humidified atmosphere enriched with 5% CO2 at 37°C.
Bacteria were harvested by gently scraping colonies off the agar surface
and resuspended in phosphate-buffered saline (PBS). A total of 1  104
bacteria were incubated with 2 105 HEK293 cells (multiplicity of infec-
tion [MOI], 0.05) in a final volume of 1 ml medium devoid of antibiotics
for 23 h.
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(iii) Monitoring bacterial growth in HEK293 cell cultures. A total of
1 104 bacteria were added to 2 105HEK293 cells (MOI, 0.05) in a final
volume of 1 ml medium devoid of antibiotics. At different times, the
medium containing bacteria and cells was collected and serially diluted.
Dilutions were plated on HIA 5% sheep blood plates. After 48 h of incu-
bation at 37°C with 5% CO2, bacterial colonies were counted.
(iv) Growth in HEK293 cell cultures in the presence of bovine mu-
cin. A total of 1 104 bacteria were incubated with 2 105 HEK293 cells
(MOI, 0.05) in a final volume of 1 ml medium devoid of antibiotics and
with 1 mg of mucin from bovine submaxillary glands (catalog number
M3895; Sigma-Aldrich).
Mutagenesis and allelic exchange. Mutagenesis ofC. canimorsus 5 wt
was performed as described in reference 36 with slight modifications. The
oligonucleotides used in this study are listed inTable S4 in the supplemen-
tal material. Briefly, replacement cassettes with flanking regions spanning
approximately 500 bp homologous to the direct target gene-framing re-
gion were constructed with a three-fragment overlapping-PCR strategy.
First, two PCRs were performed on 100 ng of C. canimorsus 5 genomic
DNA with primers A and B for the upstream flanking regions and with
primers C and D for the downstream regions. Primers B and C contained
an additional 5= 20-nucleotide extension homologous to the resistance
erm(F) insertion cassette or to the tet(Q) insertion cassette. The erm(F)
resistance cassette was amplified from plasmid pmm106 DNA (36) with
primers 5502 and 5503. The tet(Q) resistance cassette was amplified from
plasmid pfl38 DNA (see Table S3 in the supplemental material) with
primers 7180 and 7181. All three PCR products were cleaned and then
mixed in equal amounts for PCR using Phusion polymerase (Finnzymes).
The initial denaturation was at 98°C for 2 min, followed by 12 cycles
without primers to allow annealing and then elongation of the overlap-
ping fragments (98°C for 30 s, 50°C for 40 s, and 72°C for 2min). After the
addition of external primers (A and D), the program was continued with
20 cycles (98°C for 30 s, 50°C for 40 s, and 72°C for 2 min 30 s) and finally
10 min at 72°C. Final PCR products consisted of the target gene with
erm(F) or tet(Q) insertion cassettes and were then digested with PstI and
SpeI for cloning into the appropriate sites of the C. canimorsus suicide
vector pMM25 (36). Resulting plasmids were transferred by RP4-
mediated conjugative DNA transfer from E. coli S17-1 to C. canimorsus 5
to allow integration of the insertion cassette. Transconjugants were then
selected for the presence of the erm(F) or tet(Q) cassettes on erythromycin
or tetracycline plates, respectively, and then checked for sensitivity to
cefoxitin. Correct cassette insertions were confirmed by sequencing.
Construction of complementation and expression plasmids. Plas-
mids and oligonucleotides used in this study are listed in Tables S3 and S4
in the supplemental material.
(i) Construction of GlmM-, GlmU-, and GlmS-expressing vectors.
Full-length glmS and glmUwere amplified fromE. coliMG1655DNAwith
primers 7412/7413 and 7406/7407, respectively, and cloned into plasmid
pPM5 (23) intoNcoI andXhoI restriction sites, leading to plasmids pFR11
and pFR12. Full-length glmU and glmS were coamplified from E. coli
MG1655 DNA by using primers 7406 and 7413 and cloned into pPM5 by
using NcoI and XhoI restriction sites, leading to plasmid pFR13. Full-
length E. coli glmMwas amplified from E. coliMG1655DNAwith primers
7415 and 7416 and cloned downstream of the glmS gene into pFR11 by
using XhoI and SpeI restriction sites, leading to plasmid pFR14. Full-
length E. coli glmMwas amplified from E. coliMG1655DNAwith primers
7415 and 7416 and cloned downstream of the glmS gene into pFR13 by
using XhoI and SpeI restriction sites, leading to plasmid pFR15. Full-
length E. coli glmMwas amplified from E. coliMG1655DNAwith primers
7415 and 7416 and cloned downstream of the glmU gene into pFR12 by
using XhoI and SpeI restriction sites, leading to plasmid pFR16. E. coli
glmU with the first 77 codons deleted (GlmU del78) was amplified with
primers 7422 and 7407 and cloned into pFR16 by using NcoI and XhoI
restriction sites, leading to plasmid pFR17.E. coli glmUwith codons 332 to
456 deleted (GlmU Tr331) was amplified from E. coliMG1655 DNAwith
primers 7406 and 7421 and cloned into pFR16 by using NcoI and XhoI
restriction sites, leading to plasmid pFR18.
(ii) Construction of GlmUCc- and MucG-overexpressing vectors.To
generate GlmUCc with a C-terminal Strep tag, the glmUCc gene
(Ccan_15070) was amplified with primers 7442 and 7450 and cloned into
pET22B() by using NcoI and XhoI restriction sites, leading to plasmid
pFR19.
mucG (Ccan_17430), devoid of the first 21 codons and encoding a
C-terminal Strep tag, was amplified with primers 7020 and 7021 and
cloned into pET22b() by using NcoI and XhoI restriction sites, leading
to plasmid pFR22. mucG (Ccan_17430), devoid of the first 355 codons
and encoding aC-terminal Strep tag, was amplifiedwith primers 7019 and
7021 and cloned into pET22b() by usingNcoI andXhoI restriction sites,
leading to plasmid pFR23.
(iii) Construction ofmucG complementation vector. The 340-bp re-
gion upstream of themucC (Ccan_17470) starting codon sequence, con-
taining the putative mucC promoter, was cloned into pMM47A.1 vector
(36) by using SalI and NcoI restriction sites, leading to plasmid pFR20.
Full-length mucG (Ccan_17430) was amplified with primers 6923 and
6925 and cloned into pFR20 by using NcoI and XbaI restriction sites,
leading to plasmid pFR21.
(iv) Engineering MucC-Strep-His-D, -E, and -G and MucC, -D, -E,
and -G expression vectors. To engineer MucC (Ccan_17470) with a
C-terminal Strep tag, the gene mucC (Ccan_17470) was amplified with
primers 6842 and 6786 and cloned into pFR20withNcoI andXhoI restric-
tion sites in frame with the 6 His in the vector, leading to plasmid
pFR24.
Full-lengthmucD,mucE, andmucG (Ccan_17450-30) genes were am-
plified with primers 6846 and 6845 and cloned into pFR24 downstream
from mucC-Strep-His by using SpeI restriction sites, leading to plasmid
pFR26. Full-lengthmucC (Ccan_17470) was amplified with primers 6842
and 6805 and cloned into pFR20 with NcoI and XhoI restriction sites,
leading to plasmid pFR25. Full-length mucD, mucE, and mucG
(Ccan_17450-30) were amplified with primers 6846 and 6845 and cloned
into pFR25 downstream frommucC with SpeI restriction sites, leading to
plasmid pFR27.
(v) Construction of a TetQ expression vector. The tet(Q) gene was
amplified from pMM104 (36) DNA with primers 7156 and 7157 and
cloned into pPM5 by using NcoI and XbaI restriction sites, leading to
plasmid pFL38.
Microscopy pictures and movies. For each experiment, bacterial sus-
pensions were deposited onto 1% agarose pads. All microscopy images
were captured with an Axioscop (Zeiss) microscope with an Orca-Flash
4.0 camera (Hamamatsu) and Zen 2012 software (Zeiss). Images were
processed using ImageJ software.
(i) Growth curves of bacteria in cocultures with HEK293 cells. For
each time point, 10-l aliquots of bacterium-cell suspensions were trans-
ferred onto a 1% agarose pad made with PBS, and images were captured
on the microscope.
(ii) Vancomycin treatment of wt bacteria in cocultures with
HEK293 cells. wt bacteria were grown for 12 h in HEK293 cell cultures.
Vancomycin hydrochloride was then added at a final concentration of
5 g/ml. Bacteria were collected after 4 h, 10 l of the bacterium-cell
suspension was transferred onto a 1% agarose pad made with PBS, and
images were collected on the microscope.
(iii) Microscopy movies of wt bacteria treated with vancomycin.
Bacteria were grown to exponential phase on HEK293 cell cultures for
12 h in 1-ml final volumes and then resuspended. Ten microliters of the
bacterium-cell suspension was transferred onto a 1% agarose pad made
withDMEMwith 10% (vol/vol) heat-inactivated human serum (S1-Liter;
EMD Millipore) and vancomycin hydrochloride (Sigma-Aldrich) at a fi-
nal concentration of 5 g/ml. Time-lapse movies were generated by im-
aging the cells every 2 min for 12 h. During all microscopy experiments,
the stage was kept at 37°C to allow bacterial growth. Movies were gener-
ated from time-lapse images using Zen 2012 software (Zeiss).
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(iv) Microscopy movies of PUL5 mutant bacteria. PUL5 bacteria
were grown to exponential phase in HEK293 cell cultures for 12 h in 1-ml
final volumes and then resuspended. Tenmicroliters of the bacterium-cell
suspension was transferred onto a 1% agarose pad made with DMEM
with 0.5% (vol/vol) heat-inactivated human serum (S1-Liter; EMD Mil-
lipore), a condition we found allowed a few bacterial generations before
leading to growth arrest and shape change. Time-lapse movies were gen-
erated by imaging the cells every 2 min for 12 h. During all microscopy
experiments, the stage was kept at 37°C to allow bacterial growth. Movies
were generated from time-lapse images by using Zen 2012 software
(Zeiss).
Recombinant Ccan_15070 (GlmUCc) and Ccan_17430 (MucG)
overexpression and purification. E. coliBL21 bacteria harboring plasmid
pFR19, expressing a C-terminal Strep-tagged Ccan_15070, or pFR22, ex-
pressing a C-terminal Strep-tagged Ccan_17430 or harboring plasmid
pFR23, expressing C-terminal Strep-tagged Ccan_17430 devoid of the
BACONand F5/8 type C domains, were inoculated at an optical density at
600 nm (OD600) of 0.05 in 300 ml LBmediumwith ampicillin and grown
for 2 h at 37°C with agitation. To induce protein expression, isopropyl--
D-thiogalactopyranoside was added to a final concentration of 1mM, and
cells were grown for 2 more hours. Bacteria were collected by centrifuga-
tion at 5,000 g, resuspended in PBS, and lysed in a French press. Lysates
were centrifuged at 15,000  g for 15 min, and supernatants were col-
lected.
Each supernatant was loaded into a column containing 1 ml of a 50%
slurry (0.5 ml CV) Strep-Tactin Superflow resin (catalog number 2-1206-
002; IBA). The flowthrough was reloaded into the resin 2more times. The
resin was then washed 4 times with 10 CV of buffer W (100 mM Tris,
150 mM NaCl, 1 mM EDTA; pH 8), and proteins were eluted in 3 steps
with 0.5 ml elution buffer (100 mM Tris, 150 mM NaCl, 1 mM EDTA,
2.5mMdesthiobiotin; pH 8). The proteins present in the elution fractions
were visualized by Coomassie staining and immunoblotting with mouse
anti-Strep tag antibodies (MCA2489P; AbD Serotec).
UDP-GlcNAc synthesis by recombinant Ccan_15070 (GlmUCc).The
activity and substrate specificity of the enzyme Ccan_15070 was assessed
by incubating 30 g of purified recombinant Ccan_15070 protein with
1,245 g of UTP (catalog number U6625; Sigma) and 500g of GlcNAc-
1-P (A2142; Sigma) in 1ml 100mMTris-HCl (pH 7.5) and 10mMMgCl2
solution for 16 h at 37°C. As a control, the same amount of substrate was
incubated in the absence of recombinant purified Ccan_15070. UDP-
GlcNAc production was detected by HPLC using a Waters 600 E device
with a C18 Atlantis T3, 5m, 4.60- by 250-mm column. Elution was done
with 50mMtriethylimine acetic acid, pH6.8, 0.5%CH3CN; detectionwas
at 262 nm and at a flow rate of 1 ml/min.
Human salivary mucin deglycosylation and degradation analyses.
Fresh human saliva was collected from healthy volunteers and sterilized
by filtration using 0.22-m filters (Millipore). Bacteria were collected
from blood agar plates and resuspended in PBS at an optical density at
OD600 of 1. Aliquots of 100 l of bacterial suspensions (corresponding to
5 107 bacteria) were incubated with 100l of human saliva for 240min
at 37°C. As a negative control, 200l of 1:2-diluted human saliva solution
alone was incubated for 240 min at 37°C. Samples were then centrifuged
for 5 min at 13,000  g, and supernatant collected and loaded in a 10%
SDS gel. Samples were analyzed by lectin staining with PNA according to
the manufacturer’s recommendations (DIG glycan differentiation kit,
catalog number 11210238001; Roche). MG2 mucin degradation was
monitored by Western blotting with mouse anti human MG2 antibodies
(ab55542; Abcam).
Mucinase assays with purified recombinant MucG. One hundred
microliters of human saliva was incubated with 1 g of purified MucG
protein for 1.5 or 3.5 h at 37°C in the presence or absence of 50mMEDTA.
Samples were loaded onto 10% SDS-PAGE gels and analyzed by lectin
staining with PNA according to the manufacturer’s recommendations
(DIG glycan differentiation kit; Roche).
Muc proteins copurification. C. canimorsus 5 mucC bacteria har-
boring plasmid pFR26 expressing a C-terminal Strep-His double-tagged
MucC, or harboring plasmid pFR27, expressing MucC without any tag
(mock), were grown on sheep blood plates for 2 days at 37°C in the pres-
ence of 5%CO2. Bacteria from 6 plates were scraped and lysed in 35ml of
25 mM Tris-HCl, 150 mM NaCl, 0.2% Triton, 1% NP-40, 1% sodium
deoxycholate, pH 7.6.
For His affinity purification, the lysates were clarified by centrifuga-
tion (10min at 18,500 g at room temperature), and the supernatant was
diluted 1:2 in PBS, 10 mM imidazole in the presence of proteinase inhib-
itor (cOmplete Mini, EDTA-free protease Inhibitor cocktail tablets;
Roche). Aliquots of 3.5ml of a 50% slurry of chelating Sepharose fast flow
beads (GE Healthcare) were first coupled to Ni2 according to the man-
ufacturer’s instructions, and then 1.75 ml of resin was added to the solu-
tion and the mixture was incubated overnight at 4°C on a rotating wheel.
The solutionwas then loaded into a column, and the resinwaswashedfirst
with 25 column volumes (CV) of high-salt buffer (50 mM Tris, 500 mM
NaCl; pH 8) and then with 5 CV of low-salt buffer (50 mM Tris, 100 mM
NaCl; pH8). Proteins were then eluted from the resinwith 2CVof elution
buffer (50 mM Tris, 100 mM NaCl, 350 mM imidazole; pH 8). The ma-
terial eluted from the Ni2 column was then diluted 1:2 in PBS, and 1 ml
of a 50% slurry (0.5 ml CV) of Strep-Tactin superflow resin (catalog
number 2-1206-002; IBA) was added. The solution was then incubated
overnight at 4°C on a rotating wheel. Next, the solution was loaded into a
column, and the flowthrough was reloaded into the resin 2 more times.
The resin was then washed 4 times with 10 CV of bufferW (100mMTris,
150 mM NaCl, 1 mM EDTA; pH 8), and proteins were eluted in 3 steps
with 0.5 ml of elution buffer (100 mM Tris, 150 mMNaCl, 1 mM EDTA,
2.5 mM desthiobiotin; pH 8). Tagged MucC was detected by immuno-
blotting using mouse anti-His antibody (catalog number 27-4710-01;
Amersham Bioscience), and the proteins present in the elution fractions
were identified by LC/MS.
LC /MS identification of proteins in the elution fractions. Proteins
eluted from theMucC-Strep-His andMucC (mock) pulldowns were sep-
arated on a 12%SDS gel. The proteins were silver stained and excisedwith
a razor blade. Proteins were trypsin digested and analyzed by LC/MS as
described in reference 15.
Phylogenetic analyses of GlmUCc. The orthologous cluster of KEGG:
ml:Ccan_15070 (GlmUCc) was initially searched in the SSDB (KEGG)
database within the bacterial kingdom with a best-best rule. Only hits
above a threshold of 150 were further considered (137 hits). Because of
low similarity levels between GlmUCc and most of its bifunctional ho-
mologs, the cluster of orthologs was extended by searching the SSDBwith
the bifunctional GlmUortholog, with the highest similarity score (i.e., the
closest bifunctional relative of GlmUCc:dte:Dester_1461, 27% similarity).
The second search clustered 2,403 hits (including ml:Ccan_15070). The
two merged sets resulted in a cluster of 2,532 protein sequences that
were submitted for Pfam domain identification (http://pfam.xfam.org/
search#tabviewtab1). A total of 554 consensual 16S rRNA sequences
(derived from 2 to 20,843 [Bacillus] individual sequences from the Ribo-
somal Database Project website [37]) from the genera identified here were
used to determine a 16S rRNA-based phylogeny. The evolutionary history
was inferred by using the neighbor-joining method (38). The bootstrap
consensus tree inferred from 1,000 replicates (39) was taken to represent
the evolutionary history of the taxa analyzed (40). Branches correspond-
ing to partitions reproduced in less than 70% bootstrap replicates were
collapsed. The analysis involved 554 nucleotide sequences. All positions
with less than 50% site coverage were eliminated. That is, fewer than 50%
alignment gaps, missing data, and ambiguous bases were allowed at any
position. There were a total of 1,453 positions in the final data set. Evolu-
tionary analyses were conducted with MEGA6 (41).
SUPPLEMENTAL MATERIAL
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ADDENDUM IN PROOFS
During the reviewing process of this manuscript a paper was published in
Nature (doi:10.1038/nature13995) showing that human gut Bacteroidetes can
also utilize glycans via a selfish mechanism avoiding releasing polysaccharide
breakdown products which could be utilized by competitor bacteria.
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